Nicola Chiarelli

Assistant Professor in Medical Genetics

University of Brescia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nicola Chiarelli is an Assistant Professor in Medical Genetics at the University of Brescia, Italy. His research primarily focuses on Vascular Ehlers-Danlos Syndrome and Hypermobile Ehlers-Danlos Syndrome, with recent publications emphasizing proteomic analyses and the management of these conditions. His work explores the disease mechanisms and potential therapeutic targets, contributing significantly to the understanding of extracellular matrix disorders.

Articles (6)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

ITALY

View details

Nicoletta ZOPPI

Professor

University of Brescia

ITALY

View details

Massimo Salvetti

Professor

University of Brescia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicola Chiarelli

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Current Evidence and Future Perspectives in the Medical Management of Vascular Ehlers–Danlos Syndrome: Focus on Vascular Prevention

Integrative Multi-Omics Approach in Vascular Ehlers–Danlos Syndrome: Further Insights into the Disease Mechanisms by Proteomic Analysis of Patient Dermal Fibroblasts

Looking back and beyond the 2017 diagnostic criteria for hypermobile <scp>Ehlers‐Danlos</scp> syndrome: A retrospective cross‐sectional study from an Italian reference center

RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms

Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?

Application of the 2017 criteria for vascular Ehlers‐Danlos syndrome in 50 patients ascertained according to the Villefranche nosology

Collaborators (7)

MARINA VENTURINI

Maria Lorenza Muiesan

Marika Vezzoli

Marina Colombi

Nicola Laera

Nicoletta ZOPPI

Massimo Salvetti

Make your next move.